Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04698343 · ClinicalTrials.gov registry record · NA
Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication Reduction
A NA study of Restless Legs Syndrome, sponsored by Noctrix Health.
- Completed
- Registry status
- NA
- Development phase
- 21
- Enrollment target
- 2
- Study locations
NCT04698343 is a NA study of Restless Legs Syndrome that has completed, run by Noctrix Health. The registered enrollment target is 21 participants, below the 95-participant average among 14 other Restless Legs Syndrome trials with a reported enrollment target (78% lower). The trial reports 2 study locations across 2 states.
The verdict
NCT04698343, a NA study of Restless Legs Syndrome, has completed, sponsored by Noctrix Health.
- COMPLETED
- Registry status
- NA
- Development phase
- 21 participants
- Enrollment target
- 2
- Study locations
Study Summary
Prospective open-label single-arm feasibility study assessing the tolerability of opioid medication reduction in conjunction with noninvasive peripheral nerve stimulation (NPNS) for patients taking prescription opioids to treat moderate-severe primary RLS.
Conditions Studied
Interventions
- DEVICE Noninvasive Peripheral Nerve Stimulation (NPNS)
Study Locations (2)
California
- Mark J Buchfuhrer private practice - Downey
Ohio
- Ohio Sleep Medicine Institute - Dublin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 21 participants |
| Start Date | 2021-04-06 |
| Est. Completion | 2023-03-28 |
| Phase | NA |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04698343
The ClinicalTrials.gov registry entry for NCT04698343 describes a study currently listed as completed, categorized as NA. The registered enrollment target is 21 participants, a figure that helps gauge the scale of data the investigators plan to collect, below the 95-participant average among 14 other Restless Legs Syndrome trials with a reported enrollment target (78% lower). The listed sponsor is Noctrix Health, which has 8 total studies on file at ClinicalTrials.gov.
The record links to 1 condition, with Restless Legs Syndrome appearing as the primary indexed condition, and to 1 intervention - of which Noninvasive Peripheral Nerve Stimulation (NPNS) is the first listed.
NCT04698343 reports 2 study locations spanning 2 distinct geographic areas - top geographies include California, Ohio.
Frequently Asked Questions
What is clinical trial NCT04698343 about?
NCT04698343 is a clinical study titled "Noninvasive Peripheral Nerve Stimulation for Restless Legs Syndrome During Opioid Medication Reduction". Prospective open-label single-arm feasibility study assessing the tolerability of opioid medication reduction in conjunction with noninvasive peripheral nerve stimulation (NPNS) for patients taking prescription opioids to treat moderate-severe primary RLS.
What is the current status of trial NCT04698343?
This trial is currently completed. It is a NA study. The enrollment target is 21 participants. The study started on 2021-04-06. Estimated completion is 2023-03-28.
What conditions does trial NCT04698343 study?
This clinical trial studies the following conditions: Restless Legs Syndrome.
What interventions are being tested in trial NCT04698343?
The interventions under investigation include: Noninvasive Peripheral Nerve Stimulation (NPNS) (DEVICE).
Who is sponsoring clinical trial NCT04698343?
This trial is sponsored by Noctrix Health, which has 8 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04698343 being conducted?
This trial has 2 study locations across California, Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Restless Legs Syndrome
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
-
Blood Changes After Exercise in Restless Legs Syndrome
RECRUITING · NA
-
Response to an Investigational Device in Patients With Restless Legs Syndrome
ACTIVE NOT RECRUITING · NA
-
A Study on the Use of the MMF07 Foot Massager and Heat Therapy Treatments for Restless Leg Syndrome
COMPLETED · NA
-
Noninvasive Peripheral Nerve Stimulation for Medication-Refractory Primary RLS (The RESTFUL Study)
COMPLETED · NA
-
Treating Leg Symptoms in Women With X-linked Adrenoleukodystrophy
ACTIVE NOT RECRUITING · Phase 4
-
A Post-Market Study for Long-Term Effectiveness and Safety of the NTX100 for RLS
ACTIVE NOT RECRUITING
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.